2023
DOI: 10.1016/j.ajem.2022.11.023
|View full text |Cite
|
Sign up to set email alerts
|

The use of andexanet alfa and 4-factor prothrombin complex concentrate in intracranial hemorrhage

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

1
10
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
5

Relationship

0
5

Authors

Journals

citations
Cited by 8 publications
(11 citation statements)
references
References 15 publications
1
10
0
Order By: Relevance
“…We identified 18 studies for the review that fit the inclusion criteria and two systematic reviews (Figure 1). 28–45 Study characteristics for the comparative studies and the systematic reviews are reported in Tables S3–S5 28–45 …”
Section: Resultsmentioning
confidence: 99%
See 4 more Smart Citations
“…We identified 18 studies for the review that fit the inclusion criteria and two systematic reviews (Figure 1). 28–45 Study characteristics for the comparative studies and the systematic reviews are reported in Tables S3–S5 28–45 …”
Section: Resultsmentioning
confidence: 99%
“…We identified 18 studies for the review that fit the inclusion criteria and two systematic reviews (Figure 1). [28][29][30][31][32][33][34][35][36][37][38][39][40][41][42][43][44][45] Study characteristics for the comparative studies and the systematic reviews are reported in Tables S3-S5. [28][29][30][31][32][33][34][35][36][37][38][39][40][41][42][43][44][45] Three studies used ANNEXA-4 data for their andexanet alfa arms (Cohen 2022, Costa 2022, Huttner 2022) with adjusted control groups.…”
Section: Articles Includedmentioning
confidence: 99%
See 3 more Smart Citations